Innovation Award sees finalists from diverse sectors The finalists are BiolineRX, Amimon, and BioPetroClean. by Gali Weinreb BiolineRX Ltd., Amimon Inc. and BioPetroClean Ltd. are finalists in the 2009 Dun & Bradstreet Israel and Luzzatto & Luzzatto Technology Innovation Award. This is the second year that the award is being handed out.
The criteria for the award are a product that meets an existing market need, innovative breakthrough technology, exceptional business potential, and future sales or contracts.
BiolineRX is developing proprietary drugs for the treatment of schizophrenia, neuropathic pain, and damaged caused by acute myocardial infarction (heart attacks).
Amimon has developed a wireless video-modem solution for home entertainment systems.
BioPetroClean has developed a biological active chemostat treatment for treating wastewater for the oil and gas industry.
| 
